论文部分内容阅读
目的探讨帕多瓦(PADUA)评分是否能预测腹腔镜肾肿瘤射频消融术(LRFA)并发症发生的风险,根据LRFA本身的特点,改良PADUA评分系统,使其能够更好地预测LRFA的手术风险。方法回顾性分析160例单病灶肾肿瘤腹腔镜射频消融患者的临床资料,根据其术前CT进行标准的PADUA评分和改良PADUA评分(m-PADUA),分析这两种评分与手术并发症的相关性。结果标准的PADUA评分与LRFA并发症风险无明显相关性(P=0.307),而改良的PADUA评分与之有明显相关性(P=0.016)。结论标准的PADUA评分不适用于LRFA风险的预测,而改良评分能较好地预测LRFA手术风险。
Objective To investigate whether the PADUA score can predict the risk of complications of laparoscopic renal tumor radiofrequency ablation (LRFA). According to the characteristics of LRFA itself, the PADUA scoring system is improved to better predict the surgical risk of LRFA . Methods A retrospective analysis of 160 patients with single renal artery laparoscopic radiofrequency ablation clinical data, according to their preoperative CT standard PADUA score and improved PADUA score (m-PADUA), analysis of these two scores and surgical complications Sex. Results There was no significant correlation between the standard PADUA score and the risk of LRFA complications (P = 0.307), but the improved PADUA score was significantly associated with it (P = 0.016). Conclusion The standard PADUA score is not suitable for the prediction of LRFA risk, and the improved score can better predict the risk of LRFA surgery.